Request Demo
Last update 01 Nov 2024
Biosios (Beijing) Biotechnology Co., Ltd.
Last update 01 Nov 2024
Overview
Basic Info
Introduction Baisios is a company that specializes in creating innovative cell therapy solutions for cancer treatment. With a strong commitment to advancing the field of tumor biotherapy, Baisios is at the forefront of developing new technologies to improve patient outcomes. |
Tags
Nervous System Diseases
Cardiovascular Diseases
Immune System Diseases
Chemical drugs
Synthetic peptide
Monoclonal antibody
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
NCT06322394
A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase II Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset
CTR20240108
一项评价注射用BXOS110在发病3小时内治疗急性缺血性卒中的有效性和安全性的多中心、随机、双盲、安慰剂平行对照Ⅱ期临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase II clinical trial to evaluate the efficacy and safety of BXOS110 for injection in the treatment of acute ischemic stroke within 3 hours of onset
CTR20212520
评价注射用BXOS110在中国健康受试者中单次、多次给药的安全性、耐受性和药代动力学特征的单中心、随机、双盲、安慰剂对照的Ⅰ期临床研究
[Translation] A single-center, randomized, double-blind, placebo-controlled Phase I clinical study to evaluate the safety, tolerability and pharmacokinetic characteristics of single and multiple doses of BXOS110 for injection in healthy Chinese subjects
100 Clinical Results associated with Biosios (Beijing) Biotechnology Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Biosios (Beijing) Biotechnology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Biosios (Beijing) Biotechnology Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 20 Jan 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
2
Preclinical
Phase 2 Clinical
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free